Prevention of Venous Thrombosis and Thrombophlebitis in Long-Haul Flights with Pycnogenol®

Abstract

The aim of this study was to evaluate the occurrence of deep venous thrombosis (DVT) and superficial vein thrombosis (SVT) and its prophylaxis with an oral anti-edema and antithrombotic agent (Pycnogenol^®, Horphag, Research Management SA, Geneva, Switzerland) in long-haul flights, in subjects at moderate to high-risk of DVT and SVT. The study pre-included 244 pre-selected subjects; 211 were included (33 were excluded for several reasons due to logistic problems) and 198 completed the study; 13 subjects were lost for follow-up at the end of the flight, all for non-medical problems (i.e., for difficult connections). All subjects were scanned within 90 minutes before the flight and within 2 hours after disembarking. Subjects were supplemented with 100 mg Pycnogenol® per capsule. Treatment subjects received two capsules between 2 and 3 hours before flights with 250 mL of water; two capsules were taken 6 hours later with 250 mL of water and one capsule the next day. The control group received comparable placebo at the same intervals. The flight duration was on average 8 hours and 15 minutes (SD 55 min) (range, 7.45-12.33). In the control group there were five thrombotic events (one DVT and four superficial thromboses) while only nonthrombotic, localized phlebitis was observed in the Pycnogenol^®group (5.15% vs. no events; p<0.025). The ITT (intention to treat) analysis detects 13 failures in the control group (eight lost to follow up + five thrombotic events) of 105 subjects (12.4%) vs. five failures (4.7%; all lost, no thrombotic events) in the treatment group (p<0.025). No unwanted effects were observed. In conclusion, this study indicates that Pycnogenol^® treatment was effective in decreasing the number of thrombotic events (DVT and SVT) in moderate-to-high risk subjects, during long-haul flights.

Keywords

Venous thrombosis Edema Flight-microangiopathy Noninvasive investigations Ultrasound Travel Airplanes Long-haul flights Prevention Fibrinolysis

References

Geroulakos G , Hossain J , Tran T. Economy-class syndrome presenting as phlegmasia caerulea dolens. Eur J Vasc Endovasc Surg 2000;20:102.

Perry K. Blood clot kills woman after flight. Guardian 2001;23 Oct.

Homans J. Thrombosis of the deep leg veins due to prolonged sitting. N Engl J Med 1954;250:148.

Symington IS , Stack BHR . Pulmonary thromboembolism after travel. Br J Chest 1977;17:138.

Simpson K. Shelter deaths from pulmonary embolism. Lancet 1940;11:744.

Ferrari E , Chevallier T , Chapelier A , et al. Travel as a risk factor for venous thromboembolic disease: A case control study. Chest 1999;115:440.

Cruickshank JM , Gorlin R , Jennett B. Air travel and thrombotic episodes: The economy class syndrome. Lancet 1988;2:497.

Kraaijenhagen R , Haverkamp D , Koopman MMW , et al. Travel and risk of venous thrombosis. Lancet 2000;356:1492.

Sarvesvaran R. Sudden natural deaths associated with commercial air travel. Med Sci Law 1986;26:35.

10.

Landgraf H , Vanselow B , Schulte-Huerman D , et al. Economy class syndrome: Rheology fluid balance and lower leg oedema during a simulated 12-hour long-distance flight. Aviat Space Envir Med 1994;65:930.

11.

AMA Commission on Emergency Services . Medical aspects of transportation aboard commercial aircraft. JAMA 1982;247:1007.

12.

Gertler JP , Perry L , L’Italien G , et al. Ambient oxygen tension modulates endothelial fibrinolysis. J Vasc Surg 1993;18:939.

13.

Bendz B , Rostrup M , Sevre K , et al. Association between acute hypobaric hypoxia and activation of coagulation in human beings. Lancet 2000;356:1657.

14.

Belcaro G , Geroulakos G , Nicolaides AN , et al. Maladie veineuse thrombo-embolique apres vol aerien. Les etudes LONFLIT. Angeiologie 2001;53:17.

15.

Belcaro G , Geroulakos G , Nicolaides AN , et al. Venous thromboembolism from air travel. The Lonflit Study. Angiology 2001;52:369.

16.

Cesarone MR , Belcaro G , Nicolaides AN , et al. Venous thromboembolism from air travel: The Lonflit3 study. Prevention with Aspirin vs low-molecular weight-heparin (LMWH) in high-risk subjects: A randomised trial. Angiology 2002;53:1.

17.

Belcaro G. Venous thrombosis and air-travel: Prevention with aspirin or low-molecular-weight-heparin. Circulation 2001(Suppl II)104:II-528.

18.

Belcaro G , Geroulakos G , Nicolaides AN , et al. Prevention of deep venous thrombosis on long-haul flights. J Am Coll Cardiol 2002;39(Suppl 5):212A.

19.

Anonymous . Stockings, heparin found to eliminate “coach class” syndrome. American Heart Association Scientific Sessions 2001, Nov 14; 3; p 8.

20.

Rohdewald P. A review of the French maritime pine bark extract (Pycnogenol), a herbal medication with a diverse clinical pharmacology. Int J Clin Pharmacol Ther 2002;40,4:158.

21.

Petrassi C , Mastromarino A , Spartera C. Pycnogenol® in chronic venous insufficiency. Phytomedicine 2000;7(5):383.

22.

Putter M , Grotemeyer KHM , Wurthwein G , et al. Inhibition of smoking-induced platelet aggregation by aspirin and Pycnogenol. Thromb Res 1999;95:155.

23.

Schmidtke I , Schoop W. Le pycnogénol: Thérapeutique médicamenteuse de l'æème statique. J Suisse Médecine Glob 1995;3/95:114.

24.

Belcaro G , Nicolaides AN , Veller M. Venous Disorders: A Manual of Diagnosis and Treatment. Cambridge, MA: Saunders, 1996.

25.

Belcaro G , Nicolaides AN . Noninvasive Investigations in Vascular Disease. London: Imperial College Press, 2001.

26.

Belcaro G , Nicolaides AN , Stansby G. The Venous Clinic. Imperial College Press, London, 1999.

27.

Cesarone MR, Meli E. Volare con Sicurezza. Jet-leg. Il problema dell’edema e della trombosi in voli di lunga durata. Ediz Minerva Medica, Turin 2001.

28.

Thulesius O. Chronic venous insufficiency and varicose veins physiopathological sight points.Lakartidningen 1983;80(17):1791.

29.

Cesarone MR , Belcaro G , Nicolaides AN , et al. The edema tester in the evaluation of swollen limbs in venous and lymphatic disease. Panmin Med 1999;41:10.

30.

Belcaro G , Bollinger A , Hoffman U , Nicolaides AN (eds). Laser-Doppler. London: Med-Orion, 1995.

31.

Nicolaides AN . Investigation of chronic venous insufficiency: A consensus statement. Circulation 2000;102:126.

32.

Dalen JE , Hirsh J , Guyatt GH . Sixth ACCP Consensus Conference on Antithrombotic Therapy. Chest 2001;119:1(Suppl).

33.

Prevention of Venous Thromboembolism. International Consensus Statement. Edition 2002. London: Med-Orion,2002.

34.

Mendis S , Yach D , Alwan A. Air travel and venous thromboembolism. Bull WHO 2002;80:403.

35.

Belcaro G , Cesarone MR , Shah S , et al. Prevention of edema, flight microangiopathy and venous thrombosis in long flights with elastic stockings. A randomized trial: The LONFLIT 4 Concorde Edema-SSL Study. Angiology 2002;53(6):635.

36.

Cesarone MR , Belcaro G , Errichi BM , et al. The LON-FLIT4—Concorde Deep Venous Thrombosis and Edema Study: Prevention with travel stockings. Angiology 2003;54(2):143.

37.

Rosendaal FR , Buller HR , Kesteven P , Toff WD . Long haul flights and deep vein thrombosis: Who is at risk? Br J Haematol 2003;120(2):367.

38.

Campbell C , Rayner CF . Guidelines on prevention of venous thromboembolism during long haul flights. Thorax 2003;58(1):91.

39.

Schwarz T , Langenberg K , Oettler W , et al. Deep vein and isolated calf muscle vein thrombosis following long-haul flights: Pilot study. Blood Coagul Fibrinolysis 2002;13(8):755.

40.

Arya R , Barnes JA , Hossain U , et al. Long-haul flights and deep vein thrombosis: A significant risk only when additional factors are also present. Br J Haematol 2002;116(3):653.

41.

Murphy JF . The folded deckchair position: The problem of long-haul flights. Ir Med J 2001;94(9):260.

42.

Hosoi Y , Geroulakos G , Belcaro G , Sutton S. Characteristics of deep vein thrombosis associated with prolonged travel. Eur J Vasc Endovasc Surg 2002;24:235.

43.

Cesarone MR , Belcaro G , Di Renzo A , et al. The pilgrim syndrome. Epidemiology and investigations of long-travel pilgrimage-related thrombosis. Eur Venous Forum Web J 2003;1:1.